The Sp1/FOXC1/HOTTIP/LATS2/YAP/β-catenin cascade promotes malignant and metastatic progression of osteosarcoma

Mol Oncol. 2020 Oct;14(10):2678-2695. doi: 10.1002/1878-0261.12760. Epub 2020 Aug 29.

Abstract

The prognosis for osteosarcoma (OS) is dismal due to the aggressive tumor growth and high incidence of metastasis. The long noncoding RNA human homeobox A transcript at the distal tip (HOTTIP) and the transcription factor forkhead box C1 (FOXC1) present oncogenic activities in OS. Here, we aimed at gaining insights into the underlying mechanisms and their crosstalk. The expression of FOXC1 and HOTTIP in OS tissues or cell lines was examined by real-time PCR (RT-PCR) and western blot. The in vitro effects of FOXC1 or HOTTIP on cell viability, proliferation, migration, invasion, and expression of target genes were examined using MTT, colony-forming assay, wound-healing, Transwell invasion, and western blot, respectively; the in vivo effects were examined using xenograft and experimental metastasis models. Molecular control of HOTTIP on large tumor suppressor 2 (LATS2) or transactivation of FOXC1 or Sp1 on HOTTIP was assessed by combining RNA immunoprecipitation, qRT-PCR, western blot, ChIP, and luciferase assay. Both FOXC1 and HOTTIP were potently up-regulated in OS tissues and cell lines. FOXC1 and HOTTIP essentially maintained viability, proliferation, migration, and invasion of OS cells in vitro and contributed to xenograft growth or lung metastasis in vivo. Mechanistically, HOTTIP recruited enhancer of zeste homolog 2 (EZH2) and lysine-specific demethylase 1 (LSD1) to silence LATS2 and thus activated YAP/β-catenin signaling. Upstream, Sp1 activated FOXC1 and they both directly transactivated HOTTIP. In summary, we showed that the Sp1/FOXC1/HOTTIP/LATS2/YAP/β-catenin cascade presented oncogenic activities in OS cells. Targeting FOXC1 or HOTTIP may therefore prove beneficial for OS treatment.

Keywords: FOXC1; HOTTIP; LATS2; Sp1; osteosarcoma.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptor Proteins, Signal Transducing / metabolism*
  • Animals
  • Base Sequence
  • Cell Line, Tumor
  • Cell Movement / genetics
  • Cell Proliferation / genetics
  • Cell Survival / genetics
  • Disease Progression*
  • Enhancer of Zeste Homolog 2 Protein / metabolism
  • Forkhead Transcription Factors / metabolism*
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Mice, Inbred BALB C
  • Mice, Nude
  • Models, Biological
  • Neoplasm Invasiveness
  • Neoplasm Metastasis
  • Osteosarcoma / genetics
  • Osteosarcoma / metabolism
  • Osteosarcoma / pathology*
  • Phenotype
  • Promoter Regions, Genetic / genetics
  • Protein-Serine-Threonine Kinases / metabolism*
  • RNA, Long Noncoding / metabolism*
  • Signal Transduction
  • Sp1 Transcription Factor / metabolism*
  • Transcription Factors / metabolism*
  • Transcription, Genetic
  • Tumor Suppressor Proteins / metabolism*
  • Up-Regulation / genetics
  • Xenograft Model Antitumor Assays
  • beta Catenin / metabolism*

Substances

  • Adaptor Proteins, Signal Transducing
  • FOXC1 protein, human
  • Forkhead Transcription Factors
  • RNA, Long Noncoding
  • Sp1 Transcription Factor
  • Transcription Factors
  • Tumor Suppressor Proteins
  • YAP1 protein, human
  • beta Catenin
  • long noncoding RNA HOTTIP, human
  • Enhancer of Zeste Homolog 2 Protein
  • LATS2 protein, human
  • Protein-Serine-Threonine Kinases